Physician profile
Paul Borsuk
NPI 1275064297
$7,514.19
in general payments reported to CMS, 2019-2025
12 companies · $590 in 2025
The $590 reported for 2025 was more than what 92% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,325 · 2022: $3,004 · 2023: $1,945 · 2024: $649 · 2025: $590.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,106 · Travel and Lodging: $1,079.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,106.25 |
| Travel and Lodging | $1,078.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $5,030.36 | 2021-2025 | Proclaim, Eterna |
| Boston Scientific Corporation | $453.28 | 2021-2025 | Accolade Sr, General Pain Management Nmd, Wavewriter Alpha Prime 16 |
| Spr Therapeutics, INC | $438.72 | 2022-2023 | Sprint Pns System |
| Abbvie INC. | $416.25 | 2021-2024 | Botox |
| Nevro Corp. | $385.17 | 2021-2024 | Senza |
| Stratus Medical, LLC | $152.65 | 2025 | Nimbus |
| Relievant Medsystems, INC. | $149.68 | 2021 | |
| Globus Medical, INC. | $145.02 | 2025 | Senza |
| Medtronic, INC. | $126.10 | 2021-2024 | Intellis Adaptivestim |
| Allergan, INC. | $102.07 | 2021 | |
| Merck Sharp & Dohme LLC | $93.77 | 2023-2024 | Bridion |
| Avanos Medical | $21.12 | 2024 | Generator |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Borsuk listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.